• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CanBas Co Ltd

+ Add to Watchlist


1,015.0 JPY 87.0 9.38%

As of 20:35:24 ET on 12/25/2014.

Company Profile for CanBas Co Ltd (4575)

CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.

Contact Information

CanBas Co Ltd

2-2-1 Otemachi
Phone: 81-55-954-3666
Fax: 81-55-954-3668

Key Executives for CanBas Co Ltd (4575)

Takumi KawabePresidentMakoto KatozumiDirector/CFO
Kazuyoshi SakamotoDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil